Network distribution map
[Xinmin Evening News Xinmin net] more and more kinds of means to be used in refractory head and neck cancer and nasopharyngeal cancer treatment, and show good therapeutic prospects for this morning in heavy ion proton Shanghai hospital a symposium held on the topic, famous cancer experts under one roof to explore, robot 'doctor' - Leonardo da Vinci surgery, radiotherapy accuracy - proton heavy ion therapy, targeted therapy, and immune therapy and a series of cutting-edge technology and clinical data, triggered a strong interest here counterparts.
Refractory head and neck cancer is a type of malignant disease with a highly heterogeneous, patients suffering from this type of cancer survival rate is generally low. All along, the traditional concept of the people, the surgical occupies a very important position in cancer therapy and head and neck cancer, since the lesion location in the robot vessels, nerves, 'tradition' of the head and neck, the larger difficulty of operation by the US Affiliated hospital Case Medical Center, Professor PierreLavertu presentation 'doctor' - Leonardo da Vinci surgical system, become 'refractory head and neck cancer' highlights a topic.
Shanghai hospital when Dr. Kong Lin proton heavy ions in heavy ion talking about the treatment of locally recurrent nasopharyngeal carcinoma that, according to hospital clinical experience and data in the past year show that heavy ion therapy because of its physical dosimetry and radiobiology advantages aspects can be effective for recurrent nasopharyngeal carcinoma tumor irradiation and reduce normal tissue damage.
The seminar also brought the latest developments related to immunotherapy. MinYao conference Visiting Professor, director of head and neck radiotherapy Affiliated Hospital Case Medical Center in the United States, on the progress and prospects of clinical trials in head and neck were introduced immunotherapy. Immunotherapy is a kinds of drugs by activating the body's own immune system, and then kill a method of treating tumor cells .MinYao professor said that in the United States has a variety of immunotherapeutic drugs approved by the FDA for clinical treatment of certain tumors, such as advanced melanoma , prostate cancer, advanced squamous non-small cell lung cancer.
Professor MinYao hospital where, ongoing clinical studies for head and neck cancer immunotherapy, as of the current test data shows that by treating immune drug, can greatly enhance the patient's own immune function and prolong survival period.
The 'refractory Multidisciplinary Head and Neck Cancer Symposium precise treatment' by the heavy ion proton Shanghai Fudan University Cancer Hospital Hospital & heavy ion proton center, Affiliated Ninth People's Hospital, Shanghai Jiaotong University jointly organized. expert heavy ion hospital Dean Professor Lu Jiade Deputy Chairman Prof. ZHANG Chen-ping City, nine of oral and Maxillofacial Surgery hospital, director of the General Assembly, from home and abroad a total of more than 60 head and neck cancer treatment in the field participated in the seminar. (Xinmin Evening News reporter Shi Jie)
www.get-top-news.com Get Top News, Latest News and Current News from get-top-news.com. Latest Current News: U.S., China, World, Entertainment, Health, Finance, Business, echnology, Travel, Politics, Sports.Traditional Chinese: 達芬奇機器人多方合圍 鉚牢頭頸腫瘤“精準治療”